Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial
Titel:
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial
Auteur:
Zanchin, Christian Koskinas, Konstantinos C. Ueki, Yasushi Losdat, Sylvain Häner, Jonas D. Bär, Sarah Otsuka, Tatsuhiko Inderkum, Andrea Jensen, Maria Radu Juul Lonborg, Jacob Fahrni, Gregor Ondracek, Anna S. Daemen, Joost van Geuns, Robert-Jan Iglesias, Juan F. Matter, Christian M. Spirk, David Juni, Peter Mach, Francois Heg, Dik Engstrom, Thomas Lang, Irene Windecker, Stephan Räber, Lorenz